Hatsukami DK, Carroll DM. Tobacco harm reduction: past history, current controversies and a proposed approach for the future. Prev Med. 2020;140:106099.
Article PubMed PubMed Central Google Scholar
Vij N, Chandramani-Shivalingappa P, Van Westphal C, Hole R, Bodas M. Cigarette smoke-induced autophagy impairment accelerates lung aging, COPD-emphysema exacerbations and pathogenesis. Am J Physiol Cell Physiol. 2018;314:C73–c87.
Cisneros-Lira J, Gaxiola M, Ramos C, Selman M, Pardo A. Cigarette smoke exposure potentiates bleomycin-induced lung fibrosis in guinea pigs. Am J Physiol Lung Cell Mol Physiol. 2003;285:L949–956.
Article CAS PubMed Google Scholar
Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. Lancet. 2022;400:769–86.
Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199–210.
Article CAS PubMed PubMed Central Google Scholar
Zhou LL, Wang M, Liu F, Lu YZ, Song LJ, Xiong L, Xiang F, He XL, Shuai SY, Xin JB, Ye H, Yu F, Ma WL. Cigarette smoking aggravates bleomycin-induced experimental pulmonary fibrosis. Toxicol Lett. 2019;303:1–8.
Article CAS PubMed Google Scholar
Lee SW, Sharma L, Kang YA, Kim SH, Chandrasekharan S, Losier A, Brady V, Bermejo S, Andrews N, Yoon CM, Liu W, Lee JY, Kang MJ, Cruz D. Impact of cigarette smoke exposure on the lung fibroblastic response after Influenza Pneumonia. Am J Respir Cell Mol Biol. 2018;59:770–81.
Article CAS PubMed PubMed Central Google Scholar
Simoni M, Baldacci S, Puntoni R, Pistelli F, Farchi S, Lo Presti E, Pistelli R, Corbo G, Agabiti N, Basso S, Matteelli G, Di Pede F, Carrozzi L, Forastiere F, Viegi G. Respiratory symptoms/diseases and environmental tobacco smoke (ETS) in never smoker Italian women. Respir Med. 2007;101:531–8.
Strzelak A, Ratajczak A, Adamiec A, Feleszko W. Tobacco smoke induces and alters Immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review. Int J Environ Res Public Health. 2018;15:1033.
Article PubMed PubMed Central Google Scholar
Phan THG, Paliogiannis P, Nasrallah GK, Giordo R, Eid AH, Fois AG, Zinellu A, Mangoni AA, Pintus G. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis. Cell Mol Life Sci. 2021;78:2031–57.
Article CAS PubMed Google Scholar
Vanker A, Gie RP, Zar HJ. The association between environmental tobacco smoke exposure and childhood respiratory disease: a review. Expert Rev Respir Med. 2017;11:661–73.
Article CAS PubMed PubMed Central Google Scholar
Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health. 2005;4:7.
Article PubMed PubMed Central Google Scholar
Wang Q, Sundar IK, Lucas JH, Muthumalage T, Rahman I. Molecular clock REV-ERBα regulates cigarette smoke-induced pulmonary inflammation and epithelial-mesenchymal transition. JCI Insight. 2021;6:12–e145200.
Mora AL, Rojas M, Pardo A, Selman M. Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease. Nat Rev Drug Discov. 2017;16:755–72.
Article CAS PubMed Google Scholar
Tsuji T, Aoshiba K, Nagai A. Cigarette smoke induces senescence in alveolar epithelial cells. Am J Respir Cell Mol Biol. 2004;31:643–9.
Article CAS PubMed Google Scholar
Burgstaller G, Oehrle B, Gerckens M, White ES, Schiller HB, Eickelberg O. The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease. Eur Respir J. 2017;50:1601805.
Haidar A, Wigglesworth JS, Krausz T. Type IV collagen in developing human lung: a comparison between normal and hypoplastic fetal lungs. Early Hum Dev. 1990;21:175–80.
Article CAS PubMed Google Scholar
Vallet SD, Ricard-Blum S. Lysyl oxidases: from enzyme activity to extracellular matrix cross-links. Essays Biochem. 2019;63:349–64.
Article CAS PubMed Google Scholar
Laczko R, Csiszar K. Lysyl Oxidase (LOX): functional contributions to signaling pathways. Biomolecules. 2020;10:1093.
Article CAS PubMed PubMed Central Google Scholar
Setargew YFI, Wyllie K, Grant RD, Chitty JL, Cox TR. Targeting Lysyl Oxidase Family Meditated Matrix Cross-linking as an anti-stromal therapy in Solid Tumours. Cancers. 2021. https://doi.org/10.3390/cancers13030491. Cancers (Basel) 13.
Article PubMed PubMed Central Google Scholar
Conforti F, Davies ER, Calderwood CJ, Thatcher TH, Jones MG, Smart DE, Mahajan S, Alzetani A, Havelock T, Maher TM, Molyneaux PL, Thorley AJ, Tetley TD, Warner JA, Packham G, Ganesan A, Skipp PJ, Marshall BJ, Richeldi L, Sime PJ, O’Reilly KMA, Davies DE. The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis. Oncotarget. 2017;8:48737–54.
Article PubMed PubMed Central Google Scholar
Migulina N, Tjin G, Faiz A, Borghuis T, Zhao F, Kaper HJ, Metzlar M, van Dijk E, Sharma PK, Timens W, Gosens R, Brandsma CA, Burgess JK. Differential roles for lysyl oxidase (like), family members in chronic obstructive pulmonary disease; from gene and protein expression to function. Faseb j. 2022;36:e22374.
Article CAS PubMed Google Scholar
Sundar IK, Rashid K, Gerloff J, Li D, Rahman I. Genetic ablation of p16(INK4a) does not protect against cellular senescence in mouse models of chronic obstructive pulmonary disease/Emphysema. Am J Respir Cell Mol Biol. 2018;59:189–99.
Article CAS PubMed PubMed Central Google Scholar
Sundar IK, Rashid K, Sellix MT, Rahman I. The nuclear receptor and clock gene REV-ERBα regulates cigarette smoke-induced lung inflammation. Biochem Biophys Res Commun. 2017;493:1390–5.
Article CAS PubMed PubMed Central Google Scholar
Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008;40:362–82.
Article CAS PubMed Google Scholar
Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol. 2002;83:111–9.
Article CAS PubMed PubMed Central Google Scholar
Wang C, Xuan X, Yao W, Huang G, Jin J. Anti-profibrotic effects of artesunate on bleomycin-induced pulmonary fibrosis in Sprague Dawley rats. Mol Med Rep. 2015;12:1291–7.
Article CAS PubMed Google Scholar
Kitzerow O, Zucker IH, Lisco SJ, Wang HJ. Timeline of Multi-organ plasma Extravasation after Bleomycin-Induced Acute Lung Injury. Front Physiol. 2022;13:777072.
Article PubMed PubMed Central Google Scholar
Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med. 2006;173:769–76.
Article CAS PubMed Google Scholar
Hwang JW, Sundar IK, Yao H, Sellix MT, Rahman I. Circadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway. Faseb j. 2014;28:176–94.
Article CAS PubMed PubMed Central Google Scholar
Wang Q, Sundar IK, Blum JL, Ratner JR, Lucas JH, Chuang TD, Wang Y, Liu J, Rehan VK, Zelikoff JT, Rahman I. Prenatal exposure to electronic-cigarette aerosols leads to sex-dependent pulmonary extracellular-matrix remodeling and myogenesis in offspring mice. Am J Respir Cell Mol Biol. 2020;63:794–805.
Article CAS PubMed PubMed Central Google Scholar
Bellou V, Belbasis L, Evangelou E. Tobacco Smoking and Risk for Pulmonary Fibrosis: a prospective cohort study from the UK Biobank. Chest. 2021;160:983–93.
Shin YJ, Kim SH, Park CM, Kim HY, Kim IH, Yang MJ, Lee K, Kim MS. Exposure to cigarette smoke exacerbates polyhexamethylene guanidine-induced lung fibrosis in mice. J Toxicol Sci. 2021;46:487–97.
Article CAS PubMed Google Scholar
Fang L, Cheng Q, Zhao F, Cheng H, Luo Y, Bao X, Li Y, Liang X, Huang Y, Xu J, Han J, Tang Y, Tang S, Liu W, Luo Z, Feng D. Cigarette smoke exposure combined with lipopolysaccharides induced pulmonary fibrosis in mice. Respir Physiol Neurobiol. 2019;266:9–17.
Article CAS PubMed Google Scholar
Amariei DE, Dodia N, Deepak J, Hines SE, Galvin JR, Atamas SP, Todd NW. Combined pulmonary fibrosis and Emphysema: pulmonary function testing and a pathophysiology perspective. Medicina. 2019.
留言 (0)